Pacer Advisors’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.06M Sell
43,794
-12,417
-22% -$868K 0.01% 849
2025
Q1
$4.13M Buy
56,211
+769
+1% +$56.5K 0.01% 711
2024
Q4
$3.63M Buy
55,442
+498
+0.9% +$32.6K 0.01% 737
2024
Q3
$4.28M Sell
54,944
-106
-0.2% -$8.26K 0.01% 666
2024
Q2
$4.29M Sell
55,050
-216
-0.4% -$16.8K 0.01% 617
2024
Q1
$3.74M Sell
55,266
-508
-0.9% -$34.4K 0.01% 662
2023
Q4
$3.76M Buy
55,774
+3,246
+6% +$219K 0.01% 627
2023
Q3
$3.56M Buy
52,528
+8,215
+19% +$556K 0.01% 515
2023
Q2
$3.17M Sell
44,313
-13,997
-24% -$1M 0.01% 614
2023
Q1
$4.05M Buy
58,310
+17,753
+44% +$1.23M 0.02% 588
2022
Q4
$2.75M Buy
40,557
+23,405
+136% +$1.59M 0.01% 518
2022
Q3
$941K Buy
17,152
+448
+3% +$24.6K 0.01% 554
2022
Q2
$1.1M Buy
+16,704
New +$1.1M 0.01% 526
2022
Q1
Sell
-23,498
Closed -$1.37M 2286
2021
Q4
$1.37M Sell
23,498
-291
-1% -$17K 0.01% 1019
2021
Q3
$1.43M Buy
23,789
+3,250
+16% +$195K 0.02% 747
2021
Q2
$1.23M Buy
20,539
+600
+3% +$35.9K 0.02% 773
2021
Q1
$991K Sell
19,939
-1,733
-8% -$86.1K 0.02% 776
2020
Q4
$1.08M Sell
21,672
-4,840
-18% -$242K 0.02% 663
2020
Q3
$1.45M Buy
+26,512
New +$1.45M 0.03% 543
2020
Q1
Sell
-19,950
Closed -$995K 699
2019
Q4
$995K Buy
19,950
+5,902
+42% +$294K 0.04% 547
2019
Q3
$626K Buy
14,048
+5,188
+59% +$231K 0.01% 950
2019
Q2
$366K Buy
+8,860
New +$366K 0.01% 1013
2013
Q4
$605K Buy
+17,188
New +$605K 0.15% 191